Broad Application in Cardiovascular Concerns: Major Potential In 2025, crucial research activities will be developing new applications of GLP-1 receptor agonists in heart conditions, including protective effects on the heart and blood vessels, probably decreasing the risk of heart attack, stroke, and other cardiovascular events
10.1523/JNEUROSCI.3178-06.2006 15
Ongoing pharmacovigilance continues to monitor this safety signal
But while most conversations focus on weight loss alone, theres another side of the conversation that matters just as much: maintaining muscle, supporting energy levels, and building sustainable fitness habits while taking GLP-1 medications
The role of metabolic surgery is well-established in non-syndromic obesity, but its efficacy in PWS is controversial (53, 54)